Labetalol Hydrochloride
NDC 0409-0125, Labetalol Hydrochloride, injection, solution, from Hospira, Inc..
- Product NDC
- 0409-0125
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075240
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LABETALOL HYDROCHLORIDE5 mg/mL
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0409-0125-25 | 00409012525 | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25) / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/abfc6b75-1ed5-41f1-0484-4597488237bcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0409-0125
Use it
Look up 0409-0125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0409-0125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0409-0125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.